DESCRIPTION VERIFICATION OF HUMAN MEDICAL DATA Cross-Reference to Related Applications This application is a continuation-in-part of U.S. Patent Application Serial
No. 08/910,062, filed on August 6, 1997, which is a continuation-in-part of U.S. Patent Application Serial No. 08/686,21 1 , filed on July 23, 1996, which are both owned by the same entity as the instant application. Technical Field The instant invention concerns methods and apparatus for voluntarily providing medical data for humans and allowing a donor to uniquely identify blood or organs donated by that donor or another donor. Background Art
Examples of medical data collection, storage and display systems are described in U.S. Patent No. 4,737,912, entitled "Medical Image Filing Apparatus," issued to Ichikawa and in U.S. Patent No. 5,193,541 , entitled "Health Examination Method And System Using Plural Self- Test Stations And a Magnetic Card," issued to Hatsuwi. This patent describes a system for storing medical data on magnetic media contained on a card. The patient provides samples and the like to a variety of testing stations that also record self-test data on the card.
A further example is taught in U.S. Patent No. 5,325,294. entitled "Medical Privacy System," issued to Keene. This patent describes a system and method for retrieving medical data from a database and sharing these medical data voluntarily with another party while protecting against access by unauthorized parties. A feature common to such systems is a means for identifying a particular patient or client and associated medica records. Areas where such concerns arise are: (i) blood sample collection/donation, (ii) testing to determine human health characteristics, including infectious status of humans, and especially HIV status, and (iii) organ donation following the brain death of a suitable organ donor. Blood samples may be collected for various purposes, including blood typing, drug testing, testing for infectious or genetic diseases, blood donation and organ harvesting. Depending on the purpose of the donation, various specific blood specimens may be collected. For example, a patient may donate blood for autologous transfusion in anticipation of elective surgery, e.g., hip replacement. The autologous donor is also the intended recipient of the donated blood. The patient donates blood over a period
of weeks, and the donated blood is replaced by the patient's bone marrow in the normal manner. In this way, the blood lost during surgery may be replaced with the patient's own blood, which was stored in a blood bank from the time of donation until the surgery. Another situation in which quasi autologous blood donation occurs is in the context of a woman giving birth to a newborn child. The umbilicus and the placenta includes substantial quantities of blood that is laden with unique cells and substances believed to be efficacious in promoting healing and particularly in treating childhood leukemia. A growing number of women giving birth are electing to have the blood drawn from the umbilical cord and placenta following the birth, and to have this blood stored in a blood bank. The stored blood, known as "cord blood," is then available for the infant in the event that the infant requires surgery or has other need for a blood transfusion, and in particular if the infant should develop a need to regenerate bone marrow. In this case, the identification on the blood sample should not be only that of the birth mother, because the birth mother may give birth to or have previously given birth to one or more other children.
As with most specimens for laboratory testing, it is desirable to have a way of linking the specimen to the donor from which the specimen was collected. In autologous blood donation, identification linking the donor to the donated blood is critical, particularly when the patient has a blood-borne disease, e.g.. is hepatitis B or HIV positive. This linked identification is needed in order to ensure that the blood being transfused at the time of surgery was donated by the patient undergoing the surgery. Typically, the name of the donor and other identifying indicia are written by hand on a label (or, alternatively, a computer-generated label is prepared including the linking data) and the label is affixed by adhesive sticker to the sample collection receptacle side wall.
This label is attached to the receptacle side wall either after or before sample donation. Thus, prior to attachment or recording of data, the label can be inadvertently transferred with another label and affixed to another receptacle, or the data may be recorded on the wrong label, incorrectly placing the name of one patient onto a receptacle holding a sample from a different patient. This may result in erroneously reported lab results leading to improper diagnosis and treatment of the patient or improper identification of one individual as having used some drug or substance or transfusion of the wrong type of blood to a patient.
In some other settings, blood for transfusion to humans is selected based on compatibility testing. Typically, a medical technologies performs a crossmatch using a blood sample from the prospective recipient and a sample from a donated unit of blood. Testing both samples verifies that no antibodies or hemolytic agents are present in the recipient that would react against the cells in the donated unit to produce lysis of the donated red blood cells when transfused into the recipient. Several commercially available labeling systems are known whereby a unique number or bar code label can be attached to the sample blood tube holding blood collected from the prospective recipient, to the wrist band of the prospective recipient and to another label having the identical alphanumeric or bar code to be attached to the receptacle holding the crossmatch compatible donated blood unit. The label may state that testing has confirmed that the unit is compatible for transfusion to the crossmatch compatible recipient. The medical personnel tasked to administer the transfusion will thus be able to compare the number appearing on the crossmatch compatible donated blood unit container to the number on the prospective recipient wrist band and thus to administer the correct crossmatch compatible blood to the corresponding correct recipient. In a similar manner, the prospective recipient's name can be included on the wrist band attached to the recipient, and on the blood tube representing the phlebotomy sample collected from the prospective recipient. The label is usable for sample identification during crossmatch testing in the laboratory. The prospective recipient's name can appear on the label of the blood unit when such blood unit is verified as crossmatch compatible by the medical technologies in the crossmatch testing.
Limitations occur with the above-described systems, in particular where the medical personnel collecting the sample of blood from the prospective recipient inadvertently place the wrong label on a phlebotomy sample tube. The phlebotomy sample tube then bears a label having the name or number from another patient rather than the name/number of the true patient source of the phlebotomy blood sample. This happens, for example, during situations in the emergency room wherein a phlebotomist is performing phlebotomy on several patients in a row. The phlebotomist may label two tubes prior to drawing blood from two patients and by error place blood drawn from patient A into the tube labeled with the name and associated number from patient B. The resulting transfusion of blood crossmatch compatible for patient A into patient B, in some cases, leads to a serious blood incompatibility reaction occurring in patient B which may have serious adverse consequences for the health of patient B.
Another potential source of error involves the process of hanging a unit of blood at bedside whereby the nurse takes the unit or donated blood from the blood bank to a patient. Prior to infusing the blood, the nurse checks the wrist band to verify that the name and number on the container bag of blood for transfusion. This identification is not always carried out properly. For example, the nurse may only go the chart rack and check that the patient for whom the order is written is in a certain bed number. Then the nurse will go to that room and transfuse the blood into the patient occupying that bed regardless of the fact that on occasion someone on the previous nursing shift may have reassigned beds and moved the true intended recipient to another bed. Moreover, patients have been known to exchange wristbands or alternatively wristbands may be cut off while IVs are placed into wrist veins or during surgery where such wristbands are often then taped to the front of the chart, sometimes the wrong patient's chart.
Similarly, where the nurse only asks the patient his or her name verbally rather than checking the wristband, there are known to be errors. For example, a patient may not be fully functional in hearing or language and may respond inappropriately. Where the nurse has several patients needing transfusion and inadvertently takes a unit of blood intended for patient C to the bedside of patient D and then incorrectly omits reviewing the wristband data, or in reviewing the wristband data does not detect a difference in number or name where similar family names are present (as in an accident hospitalizing several family members together), then that nurse may inadvertently transfuse blood intended for patient C into patient D, resulting in a transfusion reaction in patient D.
In order to maintain a blood supply, blood banks solicit donors who donate blood. Typically, donors of blood units are first screened by the blood bank staff asking the prospective donor certain pertinent questions, i.e., taking a medical history and performing medical tests such as blood pressure, hematocrit, etc. Among these questions are those designed to identify high risk behavior such as men who have sex with men, drug abuse (especially intravenous), tattoos, history of hepatitis, medications, etc. These questions are dsigned to protect both the donor and the recipient. For example, certain high risk behavior is known to be associated with a greater risk of infectious disease in the donated unit.
Where a donor is deferred, i. e., not permitted to donate blood at one blood center, that donor may attempt to donate at another blood center. This is a risk for the blood supply since donor deferral for high risk behavior or positive test markers is
important to reduce the chance that the blood unit for transfusion might carry an infectious agent.
Although most donors are voluntary, some are paid, as for example in some centers collecting blood-derived fluids such as plasma donation centers. This economic aspect further increases the need to screen and defer donors unsuitable for donation.
Some donors deferred at one center may appear with the intent to donate at another blood donation center and try to conceal the previous deferral and the reasons for this deferral. In some cases, the deferred donor may not be truthful in answering questions at the second blood donation center, i.e., in the circumstance where the donor wishes to have a test for HIV done by the blood center rather than admit to engaging in high risk behavior. In this circumstance, the blood donation center needs a system that specifically identifies a deferred donor, i.e., one deferred by another blood donation center.
In all of these examples, samples of blood are typically collected by puncturing the skin and removing a sample of whole blood by vacuum or by the blood pressure in the donor's artery or vein, as is explained in more detail below. A tourniquet is typically applied to the arm, or in some cases, the leg, of the donor and the skin surface is swabbed with alcohol to disinfect it. Subsequently, the donor is often asked to grip a rubber grip so that the natural muscle compression leading to blood flow in the venous system is utilized to cause the vein to engorge and swell indicating that blood volume has increased in the vein. Then a needle attached to a syringe is inserted into the vein and a quantity of blood is removed. Alternatively, a needle attached to a blood bag by a length of tubing is used to collect a blood sample. A series of test tubes each having a rubber top and holding a vacuum may be sequentially punctured by a second end of the needle to collect blood samples. In some systems the blood tube may already have a bar code label attached in which case the tube in the present invention will have the label read by a bar code reader simultaneous to the biometric scan of the specimen donor. Other common means of phlebotomy or blood sample procurement are via indwelling lines such as catheters or by blood l ancet puncture of skin, e.g., an infant's heel, and subsequent daubing of blood from the skin surface into capillary tubes or on to an absorbent paper card.
The supply and delivery of compatible organs for transplantation involves time critical matching of histocompatibility characteristics of the organ donor and the organ recipient. Rapid and effective tissue typing is key to supplying kidneys, hearts, lungs etc., which may only be viable for a period of hours. While the histocompatibility
parameters of the organ recipient are determined ahead of time, those of the organ donor will most probably be determined immediately after the donor is determined to have been deceased. Following the determination of death or brain death, and the determination of histocompatibility parameters, the organs may be harvested and then transported to a location where the prospective recipient has been prepared for transplantation. Under these circumstances, it is extremely difficult to carry out all of the required procedural steps in the time frame during which the harvested organ is viable.
Further, in testing of human specimens in the laboratory, there is a need from time to time for anonymity in certain circumstances, such as in double blind studies or where the donor wishes to have anonymity, as in HIV testing or autologous blood banking of HIV positive blood. In such circumstances, one known method for accomplishing the task of secure and specific identification of the specimen to the donor while maintaining anonymity has been to attach a unique alphanumeric identifying number or code via a label that is attached to the sample collection container or device.
A first limitation of such a numerical system is that one subject may give the corresponding chit to a second individual and then the second individual may portray the test material and test results as originating from and linked to him- or her-self, rather than from the true donor. A further limitation is that the alphanumeric code, if provided to the donor or researcher in the form of a disposable paper chit, may be lost. Correlation of the test specimen and container or device may then be hindered or completely corrupted. Additionally, computerized linkage of an alphanumeric code to other data may be subject to input error by a keyboard operator.
Human disease status is highly confidential information subject to potential for misuse by any of a variety of agencies or individuals. For example, some doctors will advise patients not to seek human immunodeficiency virus (HIV) testing via the doctor because the records generated in the process of testing for HIV may be used by insurance companies to deny insurance coverage to the individual requesting the test results. Some fear governmental oversight. The reasoning seems to be that if the individual sought to ascertain HIV status information, the individual must have reason to suspect a positive HIV status. The individual therefore is adjudged likely to (i) have engaged in high-risk behavior, (ii) continue to engage in high-risk behavior and (iii) have an enhanced probability (compared to other population segments) of developing (a) HIV-positive status followed by (b) acquired immune deficiency syndrome (AIDS), presently a frequently fatal
condition. People may well be denied employment if it is suspected that they are at risk of developing an HIV-positive status or of contracting AIDS subsequent to infection by HIV.
Accordingly, it is desirable, particularly with respect to HIV testing of donated blood samples, to be tested in a way that completely protects the individual identity of the donor. One such system is provided in some states through Planned Parenthood, which collects (i) a blood sample from the donor and (ii) whatever identifying indicia the donor cares to provide, such as a pseudonym. The agency typically then (iii) links the identifying indicia, the test sample and a unique identifying code or serial number in a computer database or other log and (iv) informs the donor that test results are to be expected to be available following a set interval of one to two weeks. The one to two week interval is for shipping the test sample to a suitable laboratory or other testing facility and for receiving the results of the analysis therefrom.
The test sample and code or serial number are then (v) sent to a remote site for testing and analysis. Results are then (vi) sent back to the test site (or any other designated place). The donor (vii) returns to the test site or goes to a designated office and (viii) is advised of the test results. If warranted, (ix) appropriate counseling is provided along with follow-up services. Additionally, (x) a paper record is often provided with an indication of the test results. Unfortunately, because the donor often provides a pseudonym, a third party has no way of knowing that a particular record is actually the product of a test conducted on samples provided by the individual presenting such a record. Moreover, the paper record is easily forged or mutilated to alter the information contained thereon, in part because there is no standard or unforgeable format for such records. This system affords an individual donor great confidence in both the anonymity and the trustworthiness of the test result, but this system does not provide the donor with any verifiable way of providing credible test results to a third party. Additionally, recent multiple-drug therapies can reduce presence of HIV and indicia of HIV to immeasurably low levels. These therapies introduce detectable levels of drugs into the bloodstream of the donor but these drugs are not tested for. Accordingly, an HIV positive person could obtain an HIV negative test result.
Accordingly, it is desirable to provide reliable data on irtfcctious status of a blood unit in an anonymous fashion whereby the person viewing the data has some assurance that the data correspond to the presenting individual. However, this alone is not necessarily sufficient because identification cards and the like may not correspond
to the bearer thereof. Therefore, it is appropriate and useful to base the correlation process on parameters unique to the individual whilst continuing to ensure anonymity of the donor, the test results and the fact that the donor had the testing performed.
There is therefore a need for some form of correlation that is unique to the individual, that is not based on a photograph of the individual or the like and that does not employ a transferable or forgeable identity device (such as an identity card). The form of correlation needs to be highly reliable and also must provide "go/no-go" identification in a short period of time (e.g., a minute or less). Disclosure of the Invention In one aspect, the present invention includes a biometric identification system.
The identification system includes a first biometric scanner, a second biometric scanner, a processor coupled to the first and second biometric scanners and a read-write memory coupled to the processor. The read-write memory stores records, including biometric data. The system determines when two separate forms of biometric identifiers taken from an individual agree with previously-stored biometric data and thus links the individual to data that are associated with the previously-stored biometric indicia.
In another aspect, the present invention includes a system for sorting units by type. The system includes a biometric scanner and a processor coupled to the biometric scanner. The processor accepts biometric data from the biometric scanner and links the biometric data to other data to form a first record. The system also includes a read-write memory coupled to the processor. The read-write memory stores the first record in response to commands from the processor. A label reading device is coupled to the processor. The label reading device reads a second record from label on a unit in response to commands from the processor. The system further includes an output device coupled to the processor. The output device provides a "GO" signal when data corresponding to biometric data from the first record agree with data corresponding to biometric data from the second record and provides a "NO GO" signal when data corresponding to biometric data from the first record do not agree with data corresponding to biometric data from the second record. As a result, the system is able to match stored data to an individual based solely on biometric indicia. Brief Description of the Drawings
Figure 1 is a schematic illustration of a collecting station for (i) collecting a blood sample from a donor and (ii) obtaining correlating data pertinent to the donor, in accordance with embodiments of the present invention.
Figure 2 is a schematic illustration of a collecting station for contemporaneously (i) collecting a blood sample from a donor and (ii) obtaining correlating data pertinent to the donor, in accordance with embodiments of the present invention.
Figure 3A is a schematic illustration of a blood sample analysis laboratory and computer data entry station, in accordance with embodiments of the present invention.
Figure 3B is a block diagram showing a data format for the records stored in the computer/database of Figure 3A, in accordance with embodiments of the present invention.
Figure 4 illustrates an example of use of biometric identification in drawing blood for blood typing, in accordance with embodiments of the present invention.
Figure 5 illustrates an example of use of biometric identification in blood typing, in accordance with embodiments of the present invention.
Figure 6 is a schematic illustration of a data retrieval station, in accordance with embodiments of the present invention. Figure 7 is a flowchart describing steps involved in (i) collecting a blood sample from a donor and (ii) simultaneously collecting correlating data pertinent to the donor, in accordance with embodiments of the present invention.
Figure 8 is a flowchart describing steps involved in blood sample analysis laboratory and computer data entry in the blood sample analysis laboratory and computer data entry station of Figure 3, in accordance with embodiments of the present invention.
Figure 9 is a flowchart describing steps involved in a secure data retrieval process, in accordance with embodiments of the present invention.
Figure 10 is simplified block diagram of a system including multiple blood donation centers each equipped with the data retrieval station of Figure 6 coupled to the computer and database of Figure 3, in accordance with embodiments of the present invention.
Figure 1 1 is a simplified block diagram of multiple donation centers coupled to a database, in accordance with embodiments of the present invention. Best Modes for Carrying Out the Invention and Disclosure of Invention Figures I and 2 illustrate a data collection station 1 1 for (i) collecting a blood sample from a voluntary donor and (ii) obtaining correlating biometric data pertinent to the donor, in accordance with embodiments of the present invention. As used herein, the term "biometric data" is defined to mean a set of identifying data derived from analysis of (a) the human body anatomy of an individual, or (b) the human body function of an individual, which data is reproducible and useful for substantially uniquely
correlating to the identity of the individual from whom the data were derived. Examples from human anatomy are iris scan, fingerprint, hand geometry and facial recognition. Examples from human body function arc signature recognition and voice recognition. The data collection station 1 1 includes a sample collection device or station 12 for collecting, in response to commands from a computer 13, a sample 14 for medical testing and biometric data from a biometric identification device 18. In one embodiment of the data collection station 1 1 , the collection device 12 is a blood sample collection station. Blood specimen collection devices are available from a variety of sources including the Vacutainer line of collection devices available from Becton Dickenson Company (Rutherford, New Jersey).
The arrangement of Figure 2 provides a single apparatus 12' for contemporaneously or simultaneously (i) collecting a blood sample 14 from a donor and (ii) obtaining biometric data pertinent to the donor, in accordance with embodiments of the present invention. With these types of samples, it is established practice to label the sample container 14 either prior to or after sample collection. The procedure described, for example, in The American Association Of Blood Banks Technical Manual, R. Walker, Ed.-in.-Ch., 1 1th Ed., 1993, pp. 14- 17, on p. 15, specifies that all donor phlebotomy sample containers are to be labeled with donor identification at the donor chair but immediately prior to phlebotomy.
In many hospitals, it is written policy that the opposite occur, i.e., that phlebotomy occurs during which the donor blood enters the test tube, which is only inscribed with indicia identifying the donor after sample donation. The potential for error is present in both procedures and especially in situations where several patients with similar names but differing blood characteristics are being evaluated under emergency conditions, i.e., following an automobile accident where a number of family members are all injured in a common vehicular disaster.
One procedure for blood sample collection is as follows: (i) the patient provides positive (e g, photo) identification ("ID"); (ii) a copy of the patient ID is stapled to a requisition form; (iii) the patient's name etc. is filled out on the requisition form, together with the current date; (iv) the patient reviews the form for accuracy; (v) the patient signs a release; (vi) the container label is prepared, including the patient's name, any test that is requested, the date of collection and the collector's initials; (vii) blood samples are taken and (vii ϊ) the collector initials the seal, signs the requisition, records the date and time, lists any medications currently or recently taken, notes any
abnormalities and puts the name of requesting organization (e.g., potential or present employer, doctor) on the label.
Additionally, it will be appreciated that the sample collection station 12 may be employed, if desired, for conducting additional tests. For example, tests may be carried out for antigens or antibodies associated with infectious diseases and any other infectious or communicable conditions of the donor. This may include testing for (i) those previously successfully treated but identifiable by remaining antibodies or other indicia in samples from the donor, (ii) drugs used to treat diseases and/or (iii) "recreational" drug use, especially that associated with risk of acquiring communicable diseases, for example, via sharing of hypodermic needles, as desired or required.
It will be appreciated that detectors may be included in the blood sample collection device 12 to assess finger temperature and that sensors included with the container for the blood sample 14 can be employed to verify (i) the temperature of the specimen, (ii) that the specimen is being provided while the fingerprint is being scanned, or that the delay between initiation of these two events is only one, two, three, four or five seconds or an appropriate interval and/or (iii) that the conductivity, pH or other properties of the specimen 14 are appropriate for human blood.
In any of these embodiments, the biometric scanner 18 or 18' may provide a signal, e.g., audible or visible, to the user to inform the user that the biometric scan was successful. It will be appreciated that many different types of biometric scanners 18 could conceivably be employed to realize the desired function for the biometric scanner 18. For example, human fingerprints provide unique indicia of identity, while automatic scanning of hand geometry may also be employed for attempting to identify specific individuals. Techniques for automatically scanning fingerprints are described in U.S. Patent
No. 5,465,303, "Automated Fingerprint Classification identification System And Method," issued to Levison et al. and in U.S. Patent No. 5,222, 152, entitled "Portable Scanning Apparatus For Identification Verification," issued to Fishbine et al.
Other types of biometric data successfully used for positive identification or correlation of an individual include dental records, anatomical geometries, retinal patterns, iris patterns, speech recognition or gene sequences or other chemical biodata that uniquely identify a particular individual with a high degree of confidence in the accuracy of the identification.
One system that uses fingerprint indicia but that does not necessarily store fingerprint images per se is the SACMAN™ fingerprint scanning device available from
Secure Access Control Technologies, Inc., located at 4620 S. Valley View, Suite A, Las Vegas, Nevada. This system uses a unique form of vector analysis of rastered fingerprint data taken at a high resolution, e.g., one thousand dots per inch.
A suitably programmed computer is used to process the digital data resulting from the fingerprint scan. The computer program normalizes the data, orients the features and removes noise to optimize the image. The data are converted from raster form to vector line types, which are then employed to classify the fingerprint. The system maps a scanned fingerprint into a fixed coordinate system in order to preserve the same general origin for the fingerprint data. This system has advantages of (i) a high degree of confidence in recognition of the vector line scan data, (ii) tolerance to micro feature changes and/or print contamination and (iii) security/anonymity in that this system does not necessarily store fingerprint images per se. The system also lends itself to generation of index keys for large databases, allowing very fast identification of people or data. The term "database" is used to mean a computer-sortable collection of similar electronic records each containing data describing one or more of a population of things having one or more common properties where the records arc stored in a computer memory. By inputting data and then determining that the input data agree with a portion of one (or more) of the records, the information from the remainder of the agreeing record may be linked to the source of the data. When the data disagree with all of the stored records, the source of the data may not be linked to information in any of the stored records.
Biometric identification systems that are based on scans of irises in the human eye are described in U.S. Patent No. 5,291 ,560, entitled "Biometric Personal Identification System Based on iris Analysis," issued to Daugman and in U.S. Patent No. 4,641 ,349, entitled "Iris Recognition System," issued to Flom et al. Iris scanning systems provide certain advantages in biometric identification of individuals. The iris scan does not normally change, for example, as the individual ages or is altered by a disease process. Iris scanning does not require contact with the person or conscious action by the person. Iris scanning is able to determine that the eye is that of a living human by monitoring hippus oscillations in pupil diameter which occur once or twice per second, even under uniform lighting. Accordingly, a photograph of an iris, or a contact lens imprinted with an iris image, will not exhibit the hippus oscillations characteristic of a living human being. Modern data processing techniques permit the iris of the eye to be used as an optical fingerprint having a highly detailed pattern that is unique for each individual and that is stable over many years, independent of the
degree of dilation or contraction of the pupil of the eye. The Irisldent™ system that is marketed by Sensar Corporation of Moorestown, New Jersey is an example of a commercially available iris scanning identification system. This system is able to acquire an image of the iris when the eyelid is open from a distance of up to 36 inches using an ordinary video camera, and does not require any additional user participation. As described in U.S. Patent No. 5,291 ,560, an extremely high degree of confidence may be had in an identification that is obtained through iris scanning.
Feature recognition based on face geometry is described in U.S. Patent No. 4,975,969, entitled "Method And Apparatus For Uniquely Identifying Individuals By Particular Physical Characteristics And Security System Utilizing Same," issued to Tal and in U.S. Patent No. 5,012,522, entitled "Autonomous Face Recognition Machine," issued to Lambert. Identification techniques based on retinal patterns are described, for example, in U.S. Patent No. 5,369,415, entitled "Direct Retinal Scan Display With Planar Imager," issued to Richard et al. and in U.S. Patent No. 5,359,669, entitled "Remote Retinal Scan Identifier," issued to Shanley et al. Identification based on speech recognition is described, for example, in U.S. Patent No. 4,961 ,229, entitled "Speech Recognition System Utilizing IC Cards For Storing Unique Voice Patterns," issued to Takahashi.
Identification based on gene sequences or other chemical biodata that uniquely identify a particular individual with a high degree of confidence in the accuracy of the identification is described in U.S. Patent No. 5,270, 167, entitled "Methods Of identification Employing Antibody Profiles" and in U.S. Patent No. 4,880,750, entitled "Individual-Specific Antibody Identification Methods," both issued to Francoeur.
Automated scanning of hand geometry is another form of biometric classification suitable for use with the present invention. Hand geometry scanners are described in, for example, U.S. Patent No. 5,483,601 , entitled "Apparatus And Method For Biometric Identification Using Silhouette And Displacement images Of A Portion Of A Person's Hand" and in U.S. Patent No. 5,335,288, entitled "Apparatus And Method For Biometric identification," both issued to Faulkner; U.S. Patent No. 5,073,950, entitled "Finger Profile Identification System," issued to Colbert et al.; U.S. Patent No. 5,073,949, entitled "Personal Verification Apparatus," issued to Takeda et al.; and U.S. Patent No. 3,648,240, entitled "Personnel Identification Apparatus," issued to Jacoby et al.
An algorithm suitable for searching a database of entries for a match for any of the above-noted biometric classification techniques is described in U.S. Patent
No. 5,479,523, entitled "Constructing Classification Weights Matrices For Pattern
Recognition Systems Using Reduced Element Feature Subsets," issued to Gaborski et al.
It will be appreciated that positive correlation of biometric data need not necessarily provide unique identification of a particular individual when a second technique for associating a specific donor with a specific test result is employed. For example, when a unique serial number known to the donor is coupled with biometric indicia for providing positive correlation of the donor and sample, the degree of confidence a third party might have that the test results correspond to the individual could be quite high (even approaching certainty) even if the biometric data alone would only provide, for example, a positive correlation carrying at least 95% confidence that the subject was correctly identified (as used herein, the term "positive correlation" means "a high order of probability of identification", i.e., a 95% certainty or better of identification). This means that the biometric data need not be exhaustive and that reduced datasets may be employed for the purpose of reducing the amount of biometric data that must be collected, transmitted and correlated.
Similarly, when two different types of biometric indicia are used to correlate a blood unit to an intended recipient or to identify an individual or to correlate the individual to a record, the odds against a false rejection or a false acceptance become remarkably small. For example, a fingerprint scan coupled with an iris scan provides a high degree of confidence in identification of the individual. As a result, the resolution of the biometric data that are collected and processed need not be as high as would be required in a system that only employed one type of biometric indicator. This allows the correlation of the biometric data to be carried out with fewer data elements and thus to be more rapid. In another embodiment, one of the biometric identification steps may be carried out through an electronic scanner while another biometric identification step is carried out by a human operator. For example, an iris scan might be carried out by an electronic scanner and the result processed in a computer while a human compares a previously-stored image of a biometric indicator to an image of the same kind of biometric indicator just taken from the presenting individual. Examples of images that lend themselves to comparison by humans include facial photographs and fingerprint images. When the human operator is satisfied that the two sets of biometric data do or do not match, the human operator may input data to the computer to indicate the decision that the human operator has made regarding the comparison.
The sample collection station 1 1 yields the sample 14 and the sample 14 is then (preferably simultaneously) labeled by a labeling device 20. The sample collection station 1 1 includes an input such as a keyboard 22, whereby additional data may be entered by medical personnel for inclusion on the label of the sample 14 and/or included with biometric correlation data from the biometric correlation device 18. The test date may also be included on the label of the sample 14. Alternatively, the sample container tube may have a bar code already in place which is read by a bar code reader simultaneous to the sample donor biometric scan.
The labeling device 20 may be a conventional laser printer, bar code printer or other printing or labeling device. Biometric correlation data from the biometric correlation device 18, a serial number or other correlating indicia, the date of the test and any other desired data are then linked together and may be supplied via an external link 23 for shipment to a database (not shown in Figures 1 or 2). The labeled sample 14 may then transported to a laboratory for analysis. It will be appreciated that other types of recording media may be usefully employed for storage of the biometric information. For example, an integrated circuit or chip (not shown in Figures I or 2) may be built into the wall of the container 14 that holds the sample, which integrated circuit is coupled to a small antenna (not shown) built into or mounted on the wall of the container 14. The antenna may allow power to be electromagnetically coupled to the chip when it is in the vicinity of another antenna (e.g., built into or mounted on the needle or needle holder) that is supplying the electrical power. These antennae may also permit data to be written to the chip and read from the chip, much as data are read in electronic toll collection devices deployed around the nation (e.g., the IPASS system used in the Chicago area). Alternatively, a physical electrical interconnection could be employed, much as data arc read from and written to "smart cards" used for financial transactions.
In one embodiment of the present invention, the electronic link 23 is an encrypted digital link and may be effected via telephone line, for example. In one embodiment of the present invention, the computer 13 supplies the serial number to a printer (not illustrated), which prints out a slip bearing the optional serial number for later use by the donor.
The labeled sample 14 is transferred via a link 24 to a sample analysis station (not shown in Figures 1 and 2). Transfer via the link 24 may be by common carrier to a remote site (e.g., a central testing facility) or to another room in the same facility. This could be effected via the Confide HIV Testing Service™ provided via Direct
Access Diagnostics, a subsidiary of Johnson and Johnson, Inc. Direct Access Diagnostics has obtained FDA approval for an over-the-counter blood sample collection kit and testing procedure similar to the testing approach used by Planned Parenthood, i.e., providing the tested individual with great confidence in the accuracy of the test results but not providing a third party with any assurance that the test result corresponds to the presenting individual.
The system of Figure 2, wherein the biometric scanner 18 is integrally combined with the sample collection device 12 to provide a combined scanner/sample collection device 12', is an arrangement for the practice of the present invention. By collecting the sample 14 contemporaneously or simultaneously with assessment of biometric indicia, assurance that the sample 14 and the labeling biometric indicia correspond to one and the same person is provided without requiring the presence of a human monitor in order to ensure compliance. For example, a small blood sample 14 may be taken from the tip of one finger (e.g., the middle finger) during the scanning of biometric data from the donor's hand or at least during a single insertion of the donor's hand into the combined scanner/sample collection device 12'.
This arrangement avoids a situation that could occur if the donor were allowed to simply volunteer a previously-collected sample 14 when having biometric data collected. In the latter scenario, there is no assurance that the sample 14 actually came from the donor, rather than the donor's friend, child or pet. Apparatus for collection of small blood samples 14 are conventional in the medical industry where such procedures have been employed for decades for testing for, e.g., phenylketonuria in newborns. Semi-automatic blood sample collection apparatus are also conventional.
A first advantage of taking the test sample 14 either under supervision of a neutral medical person or in conjunction with the collection of correlating biometric data is that this assurance can be provided to third parties. An additional advantage is realized in that the donor need not reveal a personal address or telephone number to an agency, such as Direct Access Diagnostics, where this information might be discoverable by others. A further advantage accrues if the donor can only activate access to the test results by first reviewing the test result with a trained counselor or medical doctor. In-person, face-to-face counseling with appropriate compassion, concern and medical interpretation is then available to the donor in the unfortunate event of a positive test result for HIV or other curable or incurable conditions.
Figure 3A is a schematic illustration of a blood sample analysis laboratory and computer data entry/storage station 25, in accordance with an embodiment of the present
invention. Incoming samples 14 arrive via the link 24 and are identified by a label reader 26 to determine the serial number or other correlating indicia associated with the biometric data and to be associated with results of analysis of the sample 14. The sample 14 is supplied to a sample analyzer 27 via the link 24 and an analysis of the contents of the sample 14 is performed and communicated to a computer/database 29. The results of the analysis of the sample 14 are coupled to the biometric correlation data, and, if desired, to the optional serial number by the computer and database 29.
Figure 3B is a block diagram showing a data format for a computer record 36 stored in the computer/database 29 of Figure 3A, in accordance with embodiments of the present invention. With most forms of biometric identification, the amount of data 37 required in order to represent the biometric information is known, while the amount of data 38 appended to the biometric data may vary from one record 36 to another or over time within one record 36. For example, U.S. Patent No. 5,291 ,560 discusses generation of iris codes 37 having a length of 2,048 bits or 256 bytes from an iris image of 262,000 bytes (corresponding to a 512 x 512 pixel imaging device with a per-pixel resolution of one byte). The amount of biometric data that can be included in each biometric data field 37 corresponds to limits to performance of the system in identifying individuals or detecting impostors.
In contrast, when a patient's entire medical history is a portion of the medical data field 38 appended to the biometric data field 37, the medical data field 38 may be quite large and may include various kinds of graphical data, e.g., X-ray, magnetic resonance imaging or positron emission tomography data or the like. In some embodiments, the biometric data field 37 may be subdivided into several sections to accommodate, e.g., multiple fingerprints from several of one patient's fingers, multiple fingerprints from multiple people, e.g., the patient and the doctor, or a newborn and the mother, or to accommodate multiple kinds of biometric data, e.g., fingerprint data and iris data, taken from one patient or from multiple individuals. For example, collecting biometric data from both the mother and the newborn, linking these data into a single record 36 and then using that record 36 as a basis for comparison when the mother and the newborn leave the hospital can prevent the problem of a baby from a different mother being sent home with the mother that is leaving the hospital. For example, the mother's biometric data might be taken at checkout. These data, and the data taken in conjunction with the birth, may be fingerprint, iris or other biometric data. The mother's data can then be compared by the computer 29 of Figure 3 A to records 36 (Figure 3B) stored in the database 29. When a match is found, biometric data, such as fingerprint
data, from the newborn the hospital gives to the mother to take home can be compared to the biometric data stored with the mother's biometric data to determine if this is the correct newborn.
In some embodiments, a portion of the record 36 may be reserved for indicating the total size of the record 36. When an existing record 36 is found to match biometric data input as a part of storing new medical data from analysis of a new sample 14, for example, the new medical data may be appended as a new portion 38' of the medical record 36. This allows a medical history to be built up in the record 36 in a fashion that is consistent with the longitudinal view typical of Western medical practice. Figure 4 illustrates an example of use of biometric identification in drawing blood for blood typing, in accordance with embodiments of the present invention. Following collection of biometric indicia, a series of labels 40 are printed bearing data 41 having a correspondence to biometric indicia of the patient. In the examples of Figures 4 and 5, finger print data are literally reproduced on the labels 40, however, it will be appreciated that other types of biometric indicia 41 could be used and that these might be in machine-readable only form, e.g., binary data stored in a memory device that may be a nonvolatile memory integrated circuit and that forms a portion of the label 40 or blood sample container 42. Additionally, the labels 40 may optionally include a bar code 41' and/or a patient's name 41 ". In one embodiment, in a first step, a first of the series of labels 40 bearing biometric indicia 41 is attached to the blood sample container 42 containing the sample 14 (Figures I and 2) of blood from an intended transfusion recipient. In one embodiment, the biometric data are gathered from the patient and written to the label 40 as the blood sample 14 is drawn. In a second step, a second of the series of labels 40 is placed on, or data corresponding to biometric indicia 41 are written to, a wrist band 43 on that patient's wrist. In one embodiment, the data are recorded on or in the wrist band 43 as the blood sample 14 is drawn.
Figure 5 illustrates an example of use of biometric identification in blood typing, in accordance with embodiments of the present invention. In one embodiment, third through twelfth labels 40a-40j of the series of labels 40 are placed, one each on a series of blood sample containers 42a-42j, respectively. The blood sample containers 42a-42j are used during the crossmatch procedure as follows: 42a - Anti-A; 42b - Anti-B; 42c - Anti-D; 42d - Screen 1 ; 42e Screen 2; 42f - Screen 3; 42g - D control; 42h - Reverse A; 42i - Reverse B; 42j cell suspension tube containing washed red blood cells from the intended transfusion recipient, according to the procedure specified in the American
Association of Blood Banks procedure manual. Once blood aliquots from the donated units selected for crossmatch testing are tested in the standard manner and a unit 42k is found to be crossmatch compatible for the prospective recipient, the unit 42k is labeled with the label 40k representing the finding of the medical technologist that the unit 42k is compatible with the blood sample in the blood sample container 42. The unit 42k then can be linked to the patient or the patient's chart through comparison of labels 40 bearing the same biometric indicia or to the patient into whom the transfusion is to be given through re-taking of the biometric data.
When blood testing is performed for tissue typing in anticipation of transplantation, HLA (human leukocyte antigen) testing is performed. A match of donor and intended recipient HLA data indicates a substantially reduced probability of rejection of the transplanted organ.
In one embodiment, a nurse requesting blood will attach one of the series of labels 40 directly to a transfusion request form for that patient. When a nurse or orderly visits the blood bank to pick up the unit 42k identified as being crossmatch compatible, the nurse or orderly compares the data on the label 40 on the transfusion requisition to the data on the label 40 on the unit 42k to verify that the biometric indicia or data corresponding thereto are identical for the two labels 40 and 40k. The comparison may be visual or may be electronic or both. In one embodiment, prior to administering blood from the unit 42k, the nurse uses a bar code reader (not illustrated) to read the bar code 41 ' on the label 40k. The computer/database 29 of Figure 3 receives the bar code 41 ' and uses this to access the stored record 36 of the biometric data 37 corresponding to the patient. The patient then provides new biometric data, which are transmitted to the computer/database 29. The computer/database 29 then compares the stored biometric data 37 to the new biometric data and/or to the biometric data stored on the label 40k. The data 38 added to the database data 36 includes the number of the unit(s) found crossmatch compatible for that patient. In one embodiment, the biometric data recorded on the label 40k are compared to the new biometric data. When the biometric data are identical, the nurse administers the transfusion. When the biometric data do not match, the nurse does not administer the transfusion and may request a re-draw of a blood sample 14 from the patient and have this re-tested for crossmatch to identify another unit 42k. As a result, transfusion reaction in the patient is avoided.
When the biometric indicia on the label 40k comprise a rendition of a fingerprint, visual inspection of a finger print image taken from the patient and comparison to the
rendition on the label 40k may be substituted for the electronic comparison by the computer/database 29.
In one embodiment, a fluid-dispensing unit includes a tube 44 joining the fluid reservoir forming the unit 42k and a needle (not illustrated) used to administer the transfusion. The needle or the tube 44 includes a valve 45, which may be an electrically-operated valve, controlled by the computer/database 29, which provides "GO'V'NO GO" signals. In this embodiment, the valve 45 acts as a lock and does not open when the biometric data on the label 40k and the new biometric data do not match. The valve 45 opens when the biometric data on the label 40k and the new biometric data, be., that biometric data derived from a biometric scan taken from the intended recipient at the bedside by the nurse just prior to transfusion of blood from the unit 42k, do match. As a result, blood can only flow from the unit 42k to the patient when the biometric data match. The valve 45 may be coupled electronically to the computer/database 29 by a wired link or by a conventional radio frequency, ultrasonic or optical link.
When the transfusion is one involving cord blood, the unit 42k will have been labeled with biometric data taken from the newborn at or near the time of birth. These biometric data may correspond to the newborn's irises, fingerprints, palmprints, toeprints or footprints. In this way, a biometric indicator known to vary in response to aging only in size from birth onward provides positive correlation that the unit 42k of cord blood corresponds to this particular infant. A secondary data field may include the birth mother's fingerprint or other biometric data.
Figure 6 is a schematic illustration of an embodiment of a data retrieval station 46 of the present invention. The data retrieval station 46 includes the biometric identification device 18 coupled to the database 29 of the computer data entry station 25 (Figure 3) via the link 23. The data retrieval station 46 also includes a display 47 and optionally includes a data entry device 48, both also linked to the database 29 via the link 23. The data entry device 48 includes a keyboard in one embodiment of the present invention. When results from medical testing are linked to a database via a biodata key, i.e., a set of biometric data from the specimen donor, it becomes possible for the results to be registered or escrowed with a third party organization whereby another hospital or other entity may access them, e.g., view them on the display 47, using the data retrieval station 46.
Figure 7 is a flowchart describing steps involved in a process 50 for (i) collecting the blood sample 14 (Figures I and 2) from a donor and (ii) obtaining
correlating data pertinent to the donor, in accordance with embodiments of the present invention. The process 50 begins in a step 53 with taking of a biometric correlation reading that is digitized for further processing by the computer/database 29 (Figure 3) and that optionally is also linked to the date when the biometric data were taken. In the step 53, a blood sample 14 is also collected, optionally under the supervision of one or more witnesses to both sample collection, and the taking of the biometric correlation reading, in order to ensure the integrity of the data collection and correlation processes.
Alternatively, the step 53 of sample collection may be automated by, for example, combining a biometric scan with a blood sample collection device such that the sample 14 could only have come from the individual donor from whom biometric correlation data were collected. When blood samples 14 are collected, additional confirmation of the integrity of the testing and correlation processes may be effected by determining the temperature of the collected blood sample 14 (e.g., via a thermocouple, thermistor or liquid crystal thermometer) and/or by monitoring electrical conductivity or other properties of the sample 14.
Similarly, a fingerstick blood sample collected simultaneously with a finger print biometric scan by drawing the sample 14 from the finger from which the fingerprint is being taken and at the same time as the fingerprint is scanned provides similar assurances. These methods have the advantage of allowing the sample collection station 12' (Figure 2) to operate without requiring human operators while still protecting the integrity of the system, i.e., a third party could still reasonably have great confidence that the medical information derived from the sample 14 corresponds to the individual providing matching biometric data.
In a step 56, a numeric correlation number or serial number is optionally assigned by the computer 13 within the station 1 1 (Figures 1 , 2) or by the computer/database 29 of the computer data entry station 25 (Figure 3). In a step 58, the serial number, biometric data, test date and sample 14 are linked to form a record 36 (Figure 3A) by (i) printing a correlating label on the sample 14 container via the labeling device 20 (Figures 1 , 2) and (ii) transmitting the test date, biometric data and optional serial number via the link 23 to the computer/database 29 (Figure 3). In a step 59, the serial number is optionally made available to the donor via a slip from a printer (not shown). In a step 60, the labeled sample 14 is transported via the link 24 (Figures 1 , 2) to the blood sample analysis laboratory and computer data entry station 25 (Figure 3). The data collection process 50 then ends.
Figure 8 is a flowchart describing steps involved a process 70 for blood sample 14 (Figures I and 2) analysis and computer data entry in the blood sample analysis laboratory and computer data entry station 25 (Figure 3), in accordance with embodiments of the present invention. It will be understood by those of skill in the art that while the process 70 discusses blood samples 14, any medical data may be stored in accordance with the disclosed technique. The process 70 begins when incoming samples 14 are transported via the link 24 to the label reader 26 (Figure 3). In a step 72, the biodata, i.e., the biometric scan data from the specimen donor, test date and/or optional serial number on the label 40 (Figures 4 and 5) of the sample 14 are read by the label reader 26 (Figure 3). In a step 74, the sample 14 is analyzed to determine infectious status, presence of antigens or antibodies associated with past or present infectious disease of the donor and/or presence of therapeutic or "recreational" drugs or metabolites thereof. In a step 76, the results of the analysis, optionally including the date when the analysis was performed and also optionally including data describing the test parameters and/or testing institution, are linked to the sample collection date, biometric correlation data and or serial number.
A query task 78 then interrogates the database 29 using information corresponding to the biometric data from the label 40 (Figures 4 and 5) on the sample 14 to determine if the biometric data from the label 40 match any records 36 (Figure 3A) in the database 29. When the query task 78 determines that no records 36 match the biometric data from the label 40 of the sample 14, a new record 36 (Figure 3 A) is formed, comprising a biometric data portion 37 and a medical data portion 38, and the new record 36 is used to created a new entry in the database 29 (Figure 3) in a step 80. The analysis process 70 then ends. When the query task 78 determines that a record 36 does match the biometric data from the label 40 on the test sample 14, either the medical data portion 38 of the record 36 is overwritten with the new test results, or a new medical data portion 38' of the record 36 is created, including the added medical data. The new medical data portion 38' is appended to the existing record 36, in a step 82. The analysis process 70 then ends.
It is desirable to be able append additional medical data 38' to existing medical records 36 (Figure 3A) for many reasons. For example, in situations where a patient is receiving transfusions of blood for more than a few days, the blood typing and crossmatch compatibility information is updated every forty-eight hours. A fresh blood sample 14 is drawn and is tested as described above in association with Figure 5. This
is done to avoid a situation where the patient has developed a new antibody during the last 48 hours that could influence crossmatch compatibility. Accordingly, when the patient has developed an additional antibody, updating the record 36 by appending additional medical data 38' relevant to this is useful. It will be appreciated that stored data 36 may have come from another source, i.e., from a testing system outside of the system described thus far. In these instances, when it is determined that the data 38 provide an acceptable degree of integrity, these may be linked to the biometric data 37 from the donor, optionally along with data describing the provenance of the test data (including test dates, sample collection dates and the like). The resultant composite record 36 is stored in the computer/database 29 of Figure 3 in a fashion analogous to that used for data 38 derived from test samples 14 taken as indicated hereinabove.
An incidental benefit that accrues with regard to billing for lab testing and the like, especially when carried out by third party billing agencies, is a viable means to link billing records to testing charges and to the correct billable party. Often, especially within an extended family, charges are billed out inappropriately, for example, to one family member for services provided to a different family member. Similarly, when getting medical records, a resemblance of names often results in confusion when a chart for, e.g., the patient's father is pulled, despite dissimilarities in age, social security number, clinic ID number and the like. These transactions tend to be time consuming, frustrating and unnecessarily expensive. By linking the patient's biometric data to the test sample 14, the test results and thereby to the bill, human error in preparing the bills for medical services can be avoided, the correct party obtains and pays the bill and the bill can be processed more readily by insurance carriers. A biometric data terminal similar to that at the blood bank would be placed at the billing office. Those who wish to verify their bill can visit and by input of their biometric can call up the file of tests and the associated charges for which they are responsible to pay.
Figure 9 is a flowchart describing steps involved in a secure data retrieval process 90, in accordance with embodiments of the present invention. The data retrieval process 90 begins when a person, who may be, for example, a prospective blood donor, approaches the data retrieval station 46 (Figure 6). In a step 92, the biometric data collection device 18 is accessed. The biometric data collection process may be initiated by proximity to the biometric data collection device 18, may be initiated by the person who approached the biometric data collection device 1 8 or may be initiated by medical staff. In a step 94, the biometric data collected in the step 92 are transmitted to the
computer/database 29 of Figure 3 via the link 23. A query task 96 then determines if the biometric data transmitted in the step 94 match any of the records 36 (Figure 3A) that are stored in the computer/database 29.
In a step 98, the display 47 (Figure 6) provides an indication that no match was found when the query task 96 determines that no records 36 match the transmitted biometric data. The process 90 then ends.
In a step 100, in one embodiment, the computer and database 29 transmits a signal indicative of a match when the query task 96 determines that the input biometric data match corresponding biometric data 37 in the database 29. The computer 29 responds by transmitting a signal indicating that the medical data 38 are part of the computer record 36 that included the biometric data 37 that matched the transmitted biometric data. The transmitted signal may be used to provide, for example, a "GO/NO-GO" signal for a transfusion, for example, or may include the stored medical data 38. If the stored medical data 38 include a great deal of information, it may be organized or searchable by date, topic and the like in order to facilitate inspection. In a step 101 , the data are displayed on the display 47 for a predetermined interval. In a step 102, the display 47 is erased. The process 90 then ends.
The process 90 does not require identification of any kind beyond biometric data, but is compatible with other types of medical record storage that depend on a patient serial number or patient name in order to access records. Processes that rely only on these methods, and processes that combine biometric data with other information to locate records, are compatible with the system needed in order to access data using the process 90.
It will also be appreciated that in some settings, a doctor may wish to be able to store medical information in such a fashion that it can only be recalled by the patient. For example, with genetic testing for various disorders and abnormalities, there may be concern that these data, if made available or if seized from the doctor, could be used to discriminate against the individual. Some fear that if the genetic test results were known to industry, discrimination may occur against individuals with genetic predisposition to disease. Governmental and private concern for implications of a positive genetic test result, as for example for BRCA- 1 , are well known.
The need for individuals to know their own genetic predisposition and medical personnel to watch for and screen for any such disease development is key. Despite potential governmental regulations which offer protection from discrimination based on genetic predisposition, a need for allowing medical care while keeping test results private
is seen. The invention herein disclosed includes methods and systems that can accomplish this by only allowing the test results to be viewed when the patient to whom the results are pertinent provides a biometric identification.
Figure 10 is a flowchart of a process 1 10 for collecting more than one type of biometric data and using those biometric data to match to a specific record 36 (Figure 3 A) stored in the computer/database 29 of Figure 3. The process 1 10 begins with a step 1 12 of collecting first biometric data. A query task 1 14 compares the first biometric data with biometric data records 37 stored in the computer/database 29. Alternatively, the query task 1 14 may be carried out by a human operator. For example, a fingerprint match may be made by medical personnel viewing a first image from a fingerprint scan taken at the time of the donation and a second image from a fingerprint scan taken at or near the time of the comparison. When the query task 1 14 indicates that the first biometric data do not match any record 36, a first signal is activated in a step 1 16. The process 1 10 then ends. When the query task 1 14 determines that the first biometric data do match biometric data 37 in a record 36, second biometric data are collected in a step 1 18. A query task 120 then determines if the second biometric data match biometric data 37 in the same or a corresponding record 36. When the query task 120 determines that the second biometric data do not correspond to the same or a corresponding record 36, the first signal is activated in the step 1 16. When the query task 120 determines that the second biometric data do correspond to the same or a corresponding record 36, that record 36 may be accessed in a step 122 and a second signal indicates identification of the stored record 36 corresponding to that paticut in a step 124. In either case, the process 1 10 then ends. In the query task 120, the second biometric comparison, for example based on iris scans, may be carried out, where a first iris scan was taken at the time of donation and a second iris scan was taken from the same eye as the first iris scan. The second iris scan is taken at or near the time of comparison.
Where a patient has prepared for elective surgery by autologous blood specimen donation, the surgeon will, prior to the surgery, order blood to be transfused to the patient. In one embodiment, as the blood units 42 (Figure 5) are selected from the blood bank and delivered to the operating room, dual biometric datasets are used to verify the identity of the intended recipient using the process 1 10 of Figure 10.
When two different types of biometric indicia are used to correlate a blood unit 42 to an intended recipient or to identify an individual or to correlate the individual to
a record, the odds against a false rejection or a false acceptance become remarkably small. For example, a fingerprint scan coupled with an iris scan provides a high degree of confidence in identification of the individual. As a result, the resolution of the biometric data that are collected and processed need not be as high as would be required in a system that only employed one type of biometric indicator. This allows the correlation of the biometric data to be carried out with fewer data elements and thus to be more rapid.
In another embodiment, one of the biometric identification steps in the query tasks 1 14 and 120 of Figure 10 may be carried out through an electronic scanner 18 while another biometric identification step is carried out by a human operator. For example, an iris scan might be carried out by an electronic scanner 18 and the result processed in a computer 29 while a human compares a previously-stored image of a biometric indicator to an image of the same kind of biometric indicator just taken from the presenting individual. Examples of images that lend themselves to comparison by humans include facial photographs and fingerprint images. When the human operator is satisfied that the two sets of biometric data do or do not match, the human operator may input data to the computer to indicate the decision that the human operator has made regarding the comparison.
Figure 1 1 is simplified block diagram of a system 130 including multiple blood donation centers 132, 132' each equipped with the data retrieval station 46 of Figure 6 coupled to the computer and database 29 of Figure 3 in accordance with embodiments of the present invention. Each of the blood donation centers 132, 132' is able to retrieve records 36 (Figure 3A) from the central computer and database 29 using the process 90 of Figure 9 by taking a biometric reading from a person for whom a record 36 exists in the database 29. This system describes a specific embodiment adapted to use, for example, data corresponding to fingerprint data (e.g., data from the SACMAN™ system) or with data corresponding to iris data (e.g., data from the Irisldent™ system).
In an alternative embodiment, the centers 132, 132' can be other kinds of institutions likely to be visited by a substantial proportion of the population in a given geographical or geopolitical area. Examples of such institutions 132, 132' might include driver's license registration centers, voter registration centers and social security and other public benefits offices, among others. During normal business operations, biometric data may be collected using biometric identification devices analogous to biometric scanners 18 of Figures 1 , 2 and 6. Epidemiological data may also be collected and entered on a data entry device 23 (Figure 6) and coupled with the
biometric data, forming a computer record 36 (Figure 3B) that is stored in the database 29 (Figure 3A). In one embodiment, this allows a national medical/epidemiological database to be collected. The computer record 36 may be augmented with other data, e.g., identification name/number, or medical/epidemiological data from other sources. The database can be sorted based on existing records of the voter such as age, past disease markers, gender, location of residence, and other available data to allow demographic survey of disease patterns over time.
The foregoing detailed description of the various embodiments of the invention have been particularly directed toward separate facilities for data storage and data retrieval. It will be appreciated that embodiments of the invention may be equally useful for systems where data storage is also performed at each data retrieval station, for example.
It will be appreciated that a system for (optionally, anonymously) testing for infectious disease and or associated antigens or antibodies and/or other therapeutic or "recreational" drugs or metabolites has been described that does not require the donor to carry any identification card or to provide any photograph or home address to the system. The system may permit twenty-four hour access to the data in a fashion that (i) provides high credibility to the user as to the accuracy of the test result and the applicability of the test result to the user and (ii) provides high credibility to another person that the test results and test sample collection date correspond to the observable user and accurately reflect the infectious/communicable status of the donor and/or presence of associated antigens or antibodies and\or other therapeutic or "recreational" drugs as of the date of sample collection, without compromise of the identity of either party. It will be appreciated that need for a serial number or at least need for the donor to have any knowledge of a serial number could be eliminated by employing the biometric data alone as means for accessing the system. Measurement of finger temperature or observation of the scanning process by both parties each provide assurance that no facsimile of a fingerprint is being employed to "fool the system." Various changes and modifications to the embodiment herein chosen for purposes of illustration will readily occur to those skilled in the art. For example, other types of diseases or genetic predispositions may be tested for, to effectuate a combination of capabilities as may be desired tor a specific application. To the extent that such modifications and variations do not depart from the spirit of the invention, they are
intended to be included within the scope thereof which is assessed only by a fair interpretation of the following claims.
Having fully described the invention in such clear and concise terms as to enable those skilled in the art to understand and practice the same, the invention claimed is: